Clinical trial
Alfimeprase for Thrombolysis in Acute Peripheral Arterial Occlusion
NCT00073554 · ARCA Biopharma, Inc., Industry · Completed
Key facts
| NCT number | NCT00073554 |
|---|---|
| Title | Alfimeprase for Thrombolysis in Acute Peripheral Arterial Occlusion |
| Official title | A Phase 2, Multicenter, Open-Label, Dose-Escalation Study to Evaluate the Safety and Activity of Alfimeprase in Patients With Acute Peripheral Arterial Occlusion |
| Lead sponsor | ARCA Biopharma, Inc., Industry |
| Collaborators | Premier Research |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Arterial Occlusive Diseases, Peripheral Vascular Diseases, Thrombosis |
| Intervention type | Drug |
| Interventions | Alfimeprase |
| Enrollment | 100 |
| Start date | Jun 1, 2003 |
| First posted | Nov 26, 2003 |
| Last update posted | Dec 17, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: